Mineralys Therapeutics, Inc. (MLYS)
25.29
-0.36
(-1.40%)
USD |
NASDAQ |
Aug 24, 16:00
25.29
0.00 (0.00%)
After-Hours: 20:00
Mineralys Therapeutics Total Assets (Quarterly) : 667.85M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 667.85M |
| March 31, 2026 | 652.86M |
| December 31, 2025 | 661.81M |
| September 30, 2025 | 599.95M |
| June 30, 2025 | 335.72M |
| March 31, 2025 | 354.94M |
| December 31, 2024 | 205.90M |
| September 30, 2024 | 268.25M |
| June 30, 2024 | 318.49M |
| March 31, 2024 | 347.25M |
| Date | Value |
|---|---|
| December 31, 2023 | 251.64M |
| September 30, 2023 | 277.56M |
| June 30, 2023 | 291.22M |
| March 31, 2023 | 306.44M |
| December 31, 2022 | 114.44M |
| September 30, 2022 | 122.45M |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 11.12M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| MapLight Therapeutics, Inc. | 368.35M |
| Evommune, Inc. | 301.95M |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 116.94M |
| Shareholders Equity (Quarterly) | 550.92M |
| Debt to Equity Ratio | 0.1772 |
| Current Ratio | 34.46 |
| Net Debt Paydown Yield | -0.82% |